Common use of Non-exclusive Collaboration Clause in Contracts

Non-exclusive Collaboration. The Screening Program is a mutually non-exclusive collaboration. Neurocrine and Caliper are each free to work with any other company in any area, provided that the Screening Data is used by each company in accordance with Article 3 below and each party complies with the other terms of this Agreement, including but not limited to Section 2.5(c). Neurocrine acknowledges that Caliper may use, or allow third parties to use, the Screening Technology and Caliper Compounds, to (i) pursue development of drugs that may compete with drugs Neurocrine is developing, or (ii) develop assays and screen the same and similar targets as those pursued by Neurocrine, in each case subject to Section 2.5(c) (Compound Libraries), Article 6 (Confidentiality) and the other terms of this Agreement. Caliper acknowledges that Neurocrine may elect to screen certain targets in its own facility rather than in the Screening Program, and that Neurocrine may collaborate with third parties for screening, again subject to Article 6 (Confidentiality) and the other terms of this Agreement.